Abiopharma

Fortive Reports Third Quarter 2025 Results

Aclaris Therapeutics to Participate in Three November Healthcare Conferences

ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference

Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025

REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2025 Financial Results and Operational Highlights

REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2025 Financial Results and Operational Highlights

XORTX Announces Closing of US$1.1 Million Registered Direct Offering

Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company

Merck and Eisai Provide Update on Phase 3 LEAP-012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2025